LINC00941

Across TCGA pan-cancer cohorts, LINC00941 RNA differs between tumor and matched normal tissue in 14 of 18 cancer types tested, making tumor–normal expression one of LINC00941’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LINC00941 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00941 is over-expressed in tumor, although a few such as PRAD show the opposite, repressed pattern.

HNSC, COAD, and STAD are the cancer types where LINC00941 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00941 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Female	IV	+2.810	<.001	12	view →
COAD	Male	II,III,IV	+1.066	<.001	8	view →
STAD	All	All	+0.957	<.001	8	view →
THCA	All	All	+0.308	<.001	7	view →
LUSC	Male	II,III,IV	+1.389	<.001	6	view →
KIRC	Male	All	+0.319	.001	6	view →
LUAD	All	All	+0.737	<.001	5	view →
LIHC	All	All	+0.237	.005	4	view →
CHOL	All	All	+2.250	<.001	3	view →
ESCA	All	All	+2.000	.009	2	view →
PAAD	All	All	+1.757	.004	2	view →
READ	Male	All	+1.530	.037	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 14 lineages.

LINC00941–HNSC

Open the HNSC breakdown →